Gyre Therapeutics (GYRE) Other Gross PP&E Adjustments (2010 - 2026)
Gyre Therapeutics (GYRE) reported Other Gross PP&E Adjustments of $29.1 million for Q1 2026, little changed year-over-year from $29.1 million in Q1 2025, and down 1.95% on a QoQ basis from $29.7 million in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Other Gross PP&E Adjustments data on file, last reported at $29.1 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments changed 0.07% year-over-year to $29.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.1 million (changed 0.07% YoY) and the FY2025 annual result came in at $29.7 million, up 9.99% from the prior year.
- Other Gross PP&E Adjustments eased to $29.1 million in Q1 2026 per GYRE's latest filing, from $29.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $30.0 million in Q3 2025 and bottomed at -$2.2 million in Q1 2022.
- The 5-year median for Other Gross PP&E Adjustments is $26.6 million (2024), against an average of $18.5 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments plunged 36.21%; it then jumped 162364.71% in 2024.
- Tracing GYRE's Other Gross PP&E Adjustments over 5 years: stood at $19.6 million in 2022, then jumped by 33.65% to $26.2 million in 2023, then advanced by 2.92% to $27.0 million in 2024, then advanced by 9.99% to $29.7 million in 2025, then declined by 1.95% to $29.1 million in 2026.
- Per Business Quant, the three latest GYRE Other Gross PP&E Adjustments figures stand at $29.1 million (Q1 2026), $29.7 million (Q4 2025), and $30.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 29.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.11 Mn |
| Mar 31, 2026 | 29.11 Mn |
| Dec 31, 2025 | 29.69 Mn |
| Dec 31, 2025 | 29.69 Mn |
| Sep 30, 2025 | 29.98 Mn |
| Sep 30, 2025 | 29.98 Mn |
| Jun 30, 2025 | 28.96 Mn |
| Jun 30, 2025 | 28.96 Mn |
| Mar 31, 2025 | 29.09 Mn |
| Mar 31, 2025 | 29.09 Mn |
| Dec 31, 2024 | 26.99 Mn |
| Dec 31, 2024 | 26.99 Mn |
| Sep 30, 2024 | 27.77 Mn |
| Sep 30, 2024 | 27.77 Mn |
| Jun 30, 2024 | 26.27 Mn |
| Jun 30, 2024 | 26.27 Mn |
| Mar 31, 2024 | 27.59 Mn |
| Mar 31, 2024 | 27.59 Mn |
| Dec 31, 2023 | 26.23 Mn |
| Dec 31, 2023 | 26.23 Mn |
| Jun 30, 2023 | -210,000.00 |
| Jun 30, 2023 | -210,000.00 |
| Mar 31, 2023 | -17,000.00 |
| Mar 31, 2023 | -17,000.00 |
| Dec 31, 2022 | 19.62 Mn |
| Dec 31, 2022 | 19.62 Mn |
| Sep 30, 2022 | -481,000.00 |
| Sep 30, 2022 | -481,000.00 |
| Jun 30, 2022 | -1.73 Mn |
| Jun 30, 2022 | -1.73 Mn |
| Mar 31, 2022 | -2.24 Mn |
| Mar 31, 2022 | -2.24 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Sep 30, 2021 | -2.61 Mn |
| Sep 30, 2021 | -2.61 Mn |
| Jun 30, 2021 | -3.11 Mn |
| Jun 30, 2021 | -3.11 Mn |
| Mar 31, 2021 | -1.65 Mn |
| Mar 31, 2021 | -1.65 Mn |
| Dec 31, 2020 | -5.81 Mn |
| Dec 31, 2020 | -5.81 Mn |
| Sep 30, 2020 | -1.52 Mn |
| Sep 30, 2020 | -1.52 Mn |
| Jun 30, 2020 | -1.66 Mn |
| Jun 30, 2020 | -1.66 Mn |
| Mar 31, 2020 | -1.80 Mn |
| Mar 31, 2020 | -1.80 Mn |
| Dec 31, 2019 | -3.95 Mn |
| Dec 31, 2019 | -3.95 Mn |
| Sep 30, 2019 | -2.06 Mn |
| Sep 30, 2019 | -2.06 Mn |
| Jun 30, 2019 | -2.19 Mn |
| Jun 30, 2019 | -2.19 Mn |
| Mar 31, 2019 | -2.32 Mn |
| Mar 31, 2019 | -2.32 Mn |
| Dec 31, 2018 | 74,000.00 |
| Dec 31, 2018 | 74,000.00 |
| Dec 31, 2017 | 2.30 Mn |
| Dec 31, 2017 | 2.30 Mn |
| Dec 31, 2016 | 2.30 Mn |
| Dec 31, 2016 | 2.30 Mn |
| Dec 31, 2015 | 6.40 Mn |
| Dec 31, 2015 | 6.40 Mn |
| Dec 31, 2014 | 243,000.00 |
| Dec 31, 2014 | 243,000.00 |
| Dec 31, 2013 | -3.94 Mn |
| Dec 31, 2013 | -3.94 Mn |
| Sep 30, 2013 | -7.55 Mn |
| Sep 30, 2013 | -7.55 Mn |
| Jun 30, 2013 | -7.55 Mn |
| Jun 30, 2013 | -7.55 Mn |
| Dec 31, 2012 | 248,000.00 |
| Dec 31, 2012 | 248,000.00 |
| Sep 30, 2012 | -3.38 Mn |
| Sep 30, 2012 | -3.38 Mn |
| Jun 30, 2012 | -3.92 Mn |
| Jun 30, 2012 | -3.92 Mn |
| Mar 31, 2012 | -4.45 Mn |
| Mar 31, 2012 | -4.45 Mn |
| Dec 31, 2011 | 12.83 Mn |
| Dec 31, 2011 | 12.83 Mn |
| Sep 30, 2011 | -5.41 Mn |
| Sep 30, 2011 | -5.41 Mn |
| Jun 30, 2011 | -5.86 Mn |
| Jun 30, 2011 | -5.86 Mn |
| Dec 31, 2010 | -6.07 Mn |
| Dec 31, 2010 | -6.07 Mn |